SUMMARY
Computer-aided detection (CAD) systems for automated reading of chest X-rays (CXRs) have been developed and approved for tuberculosis (TB) triage in adults, but not in children. However, CXR is frequently the only adjunctive tool to clinical assessment for the evaluation of pediatric TB in primary health settings, and children would benefit from CAD models that can detect their unique clinical and radiographic features. The current literature on CAD CXR algorithms for detecting TB and other pulmonary infections in children is limited, but highlights promising models and approaches. To advance CAD for childhood TB, large, diverse, pediatric CXR datasets are required that are linked to standardized clinical and radiographic TB classifications. These datasets could be used to train or fine-tune existing algorithms for TB screening, diagnosis and severity stratification. It is critical to include children in CAD models to increase equity and reduce the global burden of TB disease.
Competing Interest Statement
SVK is employed with FIND, a non-profit organization that has been appointed by the World Health Organization (WHO) as the independent evaluator of Computer Aided Detection (CAD) software for tuberculosis for upcoming WHO guideline and pre-qualification processes. DJ, MP, and JAS have also received funding from FIND to support future CAD evaluation for children. The other authors declare no conflicts of interest.
Funding Statement
There was no funding source for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Relevant data from the referred articles are indicated in the manuscript, and cited.
